JPMorgan Downgrades Imprivata (IMPR) to Neutral

Go back to JPMorgan Downgrades Imprivata (IMPR) to Neutral

William Blair Downgrades Imprivata (IMPR) to Market Perform

October 15, 2015 7:59 AM EDT

William Blair downgraded Imprivata (NYSE: IMPR) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.

Shares of Imprivata closed at $17.31 yesterday.

... More

Leerink Partners Cuts Price Target on Imprivata (IMPR) Following 3Q Pre-Announcement

October 15, 2015 7:12 AM EDT

Leerink Partners maintained an Outperform rating on Imprivata (NYSE: IMPR), and cut the price target to $20.00 (from $23.00), following pre-announced 3Q15 results. Revenues are now expected be $28.9-29.2m vs. prior guidance of $31-31.5m, a decrease of 7%. Non-GAAP EPS are seen at ($0.23) to ($0.22) vs. prior... More

Imprivata (IMPR) Reports Below Consensus Preliminary Q3 EPS

October 14, 2015 4:20 PM EDT

Imprivata (NYSE: IMPR), the healthcare IT security company, today announced preliminary results for three months ended September 30, 2015.

Preliminary Third Quarter 2015... More